Other

Accrued liabilities

Illumina Accrued liabilities decreased by 168.1% to -$47.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.1%, from -$56.00M to -$47.00M. Over 2 years (FY 2023 to FY 2025), Accrued liabilities shows a downward trend with a -100.0% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026May 4, 2026

How to read this metric

Fluctuations reflect changes in the timing of operational expense recognition and payment cycles.

Detailed definition

This represents the net change in short-term obligations for expenses that have been incurred but not yet invoiced or pa...

Peer comparison

Standard line item in the operating section of the cash flow statement.

Metric ID: other_increase_decrease_in_accrued_liabilities

Historical Data

17 periods
 Q2 '21Q4 '21Q1 '22Q2 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$57.00M$20.00M-$45.00M$515.00M-$123.00M$152.00M-$54.00M$40.00M-$53.00M$136.00M-$489.00M-$34.00M-$56.00M-$35.00M$22.00M$69.00M-$47.00M
QoQ Change-64.9%-325.0%>999%-123.9%+223.6%-135.5%+174.1%-232.5%+356.6%-459.6%+93.0%-64.7%+37.5%+162.9%+213.6%-168.1%
YoY Change+803.5%-173.3%-70.5%+56.9%-10.5%-805.6%-185.0%-5.7%-125.7%+104.5%+302.9%+16.1%
Range-$489.00M$515.00M
CAGR-4.7%
Avg YoY Growth-7.7%
Median YoY Growth-8.1%

Frequently Asked Questions

What is Illumina's accrued liabilities?
Illumina (ILMN) reported accrued liabilities of -$47.00M in Q1 2026.
How has Illumina's accrued liabilities changed year-over-year?
Illumina's accrued liabilities increased by 16.1% year-over-year, from -$56.00M to -$47.00M.
What is the long-term trend for Illumina's accrued liabilities?
Over 2 years (2023 to 2025), Illumina's accrued liabilities has grown at a -100.0% compound annual growth rate (CAGR), from $15.00M to $0.00.
What does accrued liabilities mean?
The net change in short-term obligations for expenses incurred but not yet paid.